Haemonetics Corporation Financials

Market Capitalization $3.69 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	23.22
Forward PE	14.40
Price to Sales TTM	$2.71
Price to Book MRQ	$4.52
Enterprise to Revenue	3.35
Enterprise to EBITDA	12.81

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2025-03-29
Most Recent Quarter	2025-03-31
Profit Margin	12.32%
Operating Margin	17.20%
Return on Assets TTM	6.65%
Return on Equity TTM	18.83%

Income Statement

Revenue TTM	$1,360,824,064
Revenue per Share TTM	$27.04
Quarterly Revenue Growth	-3.70%
Gross Profit TTM	$778,545,984
EBITDA	$337,403,000
Net Income to Common TTM	$167,679,008
Diluted EPS TTM	$3.31
Quarterly Earnings Growth YoY	184.70%

Balance Sheet

Total Cash MRQ	$308,068,000
Total Cash per Share MRQ	$6.41
Total Debt MRQ	$
Total Debt to Equity MRQ	156.35
Current Ratio MRQ	1.62
Book Value per Share MRQ	$17.02

Cash Flow

Operating Cash Flow TTM	$181,724,992
Levered Free Cash Flow TTM	$183,894,000

HAE Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	48,215,899
Float Shares	47,458,150
Avg 10 Volume	579,770
Avg 30 Volume	None
Shares Short	4,059,388
Short Ratio	8.33
Short % of Shares	11.24%
% Held by Insiders	1.11%
% Held by Institutions	118.44%

Stock Price Summary

Beta	0.37
Fifty Two Week Low	$55.30
Fifty Two Week High	$94.99
Fifty Two Week Change	-10.52%
Day 50 MA	$68.82
Day 200 MA	$71.99

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date	2012-12-03